Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
PETMED EXPRESS INC
Insider Willard Jeffrey Allen of PetMed Express Inc (PETS) filed a Form 4 on September 28, 2026, to report changes in beneficial ownership of securities. This filing serves as an official record of the insider's equity transaction.…more
PETMED EXPRESS INC
Willard Jeffrey Allen, a new executive at PetMed Express Inc (PETS), has filed a Form 3 to disclose his initial beneficial ownership of company securities. This filing serves as the official record of the insider's equity holdings.…more
PETMED EXPRESS INC
PetMed Express has registered 500,000 additional shares of common stock in connection with the amendment and restatement of its 2024 Inducement Incentive Plan. These shares are intended for employee equity compensation, with a proposed maximum offering price of $1.55 per share.…more
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
PetMeds Grants Equity Awards to New Executives
PetMeds has issued equity awards to its newly appointed CEO and CTO as a material inducement for their employment. While intended to align leadership interests, these grants introduce potential share dilution.…more
●●●●●●●● ●●●●● ●●●●●●
PetMeds has appointed human capital strategy expert Dr. Tamar Elkeles as a new independent director. This move is part of the company's ongoing efforts to strengthen corporate governance and support long-term organizational growth.…more
●●●●●●●● ●●●●● ●●●●●●
PetMed Express announced that Jeff Willard will take over as CEO and President effective September 28. The company also confirmed a leadership transition involving the appointment of a new board chair.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.